Nitric Oxide Inhibits Hetero-adhesion of Cancer Cells to Endothelial Cells: Restraining Circulating Tumor Cells from Initiating Metastatic Cascade

Adhesion of circulating tumor cells (CTCs) to vascular endothelial bed becomes a crucial starting point in metastatic cascade. We hypothesized that nitric oxide (NO) may prevent cancer metastasis from happening by its direct vasodilation and inhibition of cell adhesion molecules (CAMs). Here we show...

Full description

Saved in:
Bibliographic Details
Published in:Scientific reports Vol. 4; no. 1; p. 4344
Main Authors: Lu, Yusheng, Yu, Ting, Liang, Haiyan, Wang, Jichuang, Xie, Jingjing, Shao, Jingwei, Gao, Yu, Yu, Suhong, Chen, Shuming, Wang, Lie, Jia, Lee
Format: Journal Article
Language:English
Published: London Nature Publishing Group UK 11.03.2014
Nature Publishing Group
Subjects:
ISSN:2045-2322, 2045-2322
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Adhesion of circulating tumor cells (CTCs) to vascular endothelial bed becomes a crucial starting point in metastatic cascade. We hypothesized that nitric oxide (NO) may prevent cancer metastasis from happening by its direct vasodilation and inhibition of cell adhesion molecules (CAMs). Here we show that S-nitrosocaptopril (CAP-NO, a typical NO donor) produced direct vasorelaxation that can be antagonized by typical NO scavenger hemoglobin and guanylate cyclase inhibitor. Cytokines significantly stimulated production of typical CAMs by the highly-purified human umbilical vein endothelial cells (HUVECs). CAP-NO inhibited expression of the stimulated CAMs (particularly VCAM-1) and the resultant hetero-adhesion of human colorectal cancer cells HT-29 to the HUVECs in a concentration-dependent manner. The same concentration of CAP-NO, however, did not significantly affect cell viability, cell cycle and mitochondrial membrane potential of HT-29, thus excluding the possibility that inhibition of the hetero-adhesion was caused by cytotoxicity by CAP-NO on HT-29. Hemoglobin reversed the inhibition of CAP-NO on both the hetero-adhesion between HT-29 and HUVECs and VCAM-1 expression. These data demonstrate that CAP-NO, by directly releasing NO, produces vasorelaxation and interferes with hetero-adhesion of cancer cells to vascular endothelium via down-regulating expression of CAMs. The study highlights the importance of NO in cancer metastatic prevention.
AbstractList Adhesion of circulating tumor cells (CTCs) to vascular endothelial bed becomes a crucial starting point in metastatic cascade. We hypothesized that nitric oxide (NO) may prevent cancer metastasis from happening by its direct vasodilation and inhibition of cell adhesion molecules (CAMs). Here we show that S-nitrosocaptopril (CAP-NO, a typical NO donor) produced direct vasorelaxation that can be antagonized by typical NO scavenger hemoglobin and guanylate cyclase inhibitor. Cytokines significantly stimulated production of typical CAMs by the highly-purified human umbilical vein endothelial cells (HUVECs). CAP-NO inhibited expression of the stimulated CAMs (particularly VCAM-1) and the resultant hetero-adhesion of human colorectal cancer cells HT-29 to the HUVECs in a concentration-dependent manner. The same concentration of CAP-NO, however, did not significantly affect cell viability, cell cycle and mitochondrial membrane potential of HT-29, thus excluding the possibility that inhibition of the hetero-adhesion was caused by cytotoxicity by CAP-NO on HT-29. Hemoglobin reversed the inhibition of CAP-NO on both the hetero-adhesion between HT-29 and HUVECs and VCAM-1 expression. These data demonstrate that CAP-NO, by directly releasing NO, produces vasorelaxation and interferes with hetero-adhesion of cancer cells to vascular endothelium via down-regulating expression of CAMs. The study highlights the importance of NO in cancer metastatic prevention.
Adhesion of circulating tumor cells (CTCs) to vascular endothelial bed becomes a crucial starting point in metastatic cascade. We hypothesized that nitric oxide (NO) may prevent cancer metastasis from happening by its direct vasodilation and inhibition of cell adhesion molecules (CAMs). Here we show that S-nitrosocaptopril (CAP-NO, a typical NO donor) produced direct vasorelaxation that can be antagonized by typical NO scavenger hemoglobin and guanylate cyclase inhibitor. Cytokines significantly stimulated production of typical CAMs by the highly-purified human umbilical vein endothelial cells (HUVECs). CAP-NO inhibited expression of the stimulated CAMs (particularly VCAM-1) and the resultant hetero-adhesion of human colorectal cancer cells HT-29 to the HUVECs in a concentration-dependent manner. The same concentration of CAP-NO, however, did not significantly affect cell viability, cell cycle and mitochondrial membrane potential of HT-29, thus excluding the possibility that inhibition of the hetero-adhesion was caused by cytotoxicity by CAP-NO on HT-29. Hemoglobin reversed the inhibition of CAP-NO on both the hetero-adhesion between HT-29 and HUVECs and VCAM-1 expression. These data demonstrate that CAP-NO, by directly releasing NO, produces vasorelaxation and interferes with hetero-adhesion of cancer cells to vascular endothelium via down-regulating expression of CAMs. The study highlights the importance of NO in cancer metastatic prevention.Adhesion of circulating tumor cells (CTCs) to vascular endothelial bed becomes a crucial starting point in metastatic cascade. We hypothesized that nitric oxide (NO) may prevent cancer metastasis from happening by its direct vasodilation and inhibition of cell adhesion molecules (CAMs). Here we show that S-nitrosocaptopril (CAP-NO, a typical NO donor) produced direct vasorelaxation that can be antagonized by typical NO scavenger hemoglobin and guanylate cyclase inhibitor. Cytokines significantly stimulated production of typical CAMs by the highly-purified human umbilical vein endothelial cells (HUVECs). CAP-NO inhibited expression of the stimulated CAMs (particularly VCAM-1) and the resultant hetero-adhesion of human colorectal cancer cells HT-29 to the HUVECs in a concentration-dependent manner. The same concentration of CAP-NO, however, did not significantly affect cell viability, cell cycle and mitochondrial membrane potential of HT-29, thus excluding the possibility that inhibition of the hetero-adhesion was caused by cytotoxicity by CAP-NO on HT-29. Hemoglobin reversed the inhibition of CAP-NO on both the hetero-adhesion between HT-29 and HUVECs and VCAM-1 expression. These data demonstrate that CAP-NO, by directly releasing NO, produces vasorelaxation and interferes with hetero-adhesion of cancer cells to vascular endothelium via down-regulating expression of CAMs. The study highlights the importance of NO in cancer metastatic prevention.
ArticleNumber 4344
Author Wang, Jichuang
Wang, Lie
Jia, Lee
Gao, Yu
Lu, Yusheng
Liang, Haiyan
Shao, Jingwei
Chen, Shuming
Yu, Suhong
Xie, Jingjing
Yu, Ting
Author_xml – sequence: 1
  givenname: Yusheng
  surname: Lu
  fullname: Lu, Yusheng
  organization: Cancer Metastasis Alert and Prevention Center, College of Chemistry and Chemical Engineering, Fuzhou University
– sequence: 2
  givenname: Ting
  surname: Yu
  fullname: Yu, Ting
  organization: Cancer Metastasis Alert and Prevention Center, College of Chemistry and Chemical Engineering, Fuzhou University
– sequence: 3
  givenname: Haiyan
  surname: Liang
  fullname: Liang, Haiyan
  organization: Cancer Metastasis Alert and Prevention Center, College of Chemistry and Chemical Engineering, Fuzhou University
– sequence: 4
  givenname: Jichuang
  surname: Wang
  fullname: Wang, Jichuang
  organization: Cancer Metastasis Alert and Prevention Center, College of Chemistry and Chemical Engineering, Fuzhou University
– sequence: 5
  givenname: Jingjing
  surname: Xie
  fullname: Xie, Jingjing
  organization: Cancer Metastasis Alert and Prevention Center, College of Chemistry and Chemical Engineering, Fuzhou University
– sequence: 6
  givenname: Jingwei
  surname: Shao
  fullname: Shao, Jingwei
  organization: Cancer Metastasis Alert and Prevention Center, College of Chemistry and Chemical Engineering, Fuzhou University
– sequence: 7
  givenname: Yu
  surname: Gao
  fullname: Gao, Yu
  organization: Cancer Metastasis Alert and Prevention Center, College of Chemistry and Chemical Engineering, Fuzhou University
– sequence: 8
  givenname: Suhong
  surname: Yu
  fullname: Yu, Suhong
  organization: Cancer Metastasis Alert and Prevention Center, College of Chemistry and Chemical Engineering, Fuzhou University
– sequence: 9
  givenname: Shuming
  surname: Chen
  fullname: Chen, Shuming
  organization: Surgery Department, Fuzhou General Hospital
– sequence: 10
  givenname: Lie
  surname: Wang
  fullname: Wang, Lie
  organization: Surgery Department, Fuzhou General Hospital
– sequence: 11
  givenname: Lee
  surname: Jia
  fullname: Jia, Lee
  organization: Cancer Metastasis Alert and Prevention Center, College of Chemistry and Chemical Engineering, Fuzhou University
BackLink https://www.ncbi.nlm.nih.gov/pubmed/24614329$$D View this record in MEDLINE/PubMed
BookMark eNptkt9rFDEQx4NUbK198B-QgC8qrM2vvd34IMhSbaFakPocssnsXcpeciZZ0X_Dv9gc2yvX1rxkyHxm5juZeY4OfPCA0EtK3lPC29MUYUMEF-IJOmJE1BXjjB3s2YfoJKUbUk7NpKDyGTpkYkEFZ_II_f3mcnQGX_12FvCFX7ne5YTPIUMMlbYrSC54HAbcaW8g4g7GMeEc8Jm3Ia9gdHqcHz_g75By1M47v8Sdi2Yadd7a19M67CKHGNaljstu9n2FrFMutikVktEWXqCngx4TnNzex-jH57Pr7ry6vPpy0X26rIzgba6sbKWWC9D90AO0QKysB0F1LWxvhGWyb4kg3BrRkFr20iwI7TlpLHBWN73hx-jjnHcz9WuwBnwRP6pNdGsd_6ignbrv8W6lluGX4lJIJtqS4M1tghh-TqV3tXbJlC61hzAlRWuyaCRtuSjo6wfoTZiiL-0p2sqmJUw2daFe7Su6k7IbVwFOZ8DEkMrgB2Xc9u_CVqAbFSVquxPqbidKxNsHEbuk_2PfzWwqjF9C3BP5CP4HsaDIMg
CitedBy_id crossref_primary_10_1186_s13046_021_02104_4
crossref_primary_10_3389_fphar_2024_1355650
crossref_primary_10_1038_s41598_017_02054_y
crossref_primary_10_1158_1078_0432_CCR_20_1523
crossref_primary_10_7717_peerj_4506
crossref_primary_10_1016_j_biopha_2017_03_076
crossref_primary_10_1038_srep07830
crossref_primary_10_1016_j_niox_2025_02_002
crossref_primary_10_1038_s41467_019_13316_w
crossref_primary_10_1002_cncr_29444
crossref_primary_10_18632_oncotarget_3261
crossref_primary_10_3389_fphar_2022_960375
crossref_primary_10_1002_smll_201600550
crossref_primary_10_1016_j_ejphar_2016_08_018
crossref_primary_10_1016_j_yexcr_2018_12_015
crossref_primary_10_1016_j_bbcan_2023_189001
crossref_primary_10_3389_fphys_2020_595526
crossref_primary_10_1016_j_fct_2023_113654
crossref_primary_10_1038_srep22388
crossref_primary_10_1002_adfm_201403556
crossref_primary_10_1016_j_jep_2025_119907
crossref_primary_10_3390_cancers13112610
crossref_primary_10_1016_j_ecoenv_2016_04_022
crossref_primary_10_1039_C8SC00167G
crossref_primary_10_1016_j_envpol_2019_113390
crossref_primary_10_1038_srep30549
crossref_primary_10_12688_f1000research_6789_1
crossref_primary_10_1371_journal_pone_0204418
crossref_primary_10_1186_s12951_015_0072_x
crossref_primary_10_1016_j_phrs_2018_09_005
crossref_primary_10_1016_j_niox_2019_03_002
crossref_primary_10_1186_s12885_018_4445_z
crossref_primary_10_1186_s13058_018_1013_z
crossref_primary_10_1002_ente_201500028
crossref_primary_10_1007_s00540_019_02699_1
crossref_primary_10_1158_1078_0432_CCR_17_2008
crossref_primary_10_1039_C9NR00732F
crossref_primary_10_1208_s12248_017_0134_0
crossref_primary_10_1016_j_ejps_2019_105100
crossref_primary_10_3389_fimmu_2024_1480596
crossref_primary_10_1002_smll_201803601
crossref_primary_10_1016_j_phrs_2018_10_020
crossref_primary_10_3892_ijo_2018_4582
crossref_primary_10_1016_j_freeradbiomed_2018_09_020
crossref_primary_10_1016_j_jconrel_2021_01_030
crossref_primary_10_1080_14737159_2019_1597708
Cites_doi 10.1371/journal.pone.0001826
10.1007/BF01307187
10.1161/hh0801.089861
10.1091/mbc.2.5.347
10.1097/00005344-199424060-00002
10.1016/S0014-2999(99)00794-3
10.1038/nature09557
10.1038/sj.cr.7290133
10.1161/01.CIR.94.7.1682
10.1073/pnas.81.18.5739
10.1016/S1359-6101(98)00024-0
10.1038/nrc3125
10.1172/JCI107470
10.1016/j.canlet.2012.11.017
10.1161/01.CIR.89.5.2176
10.1172/JCI113753
10.1126/science.2588007
10.1126/science.1701274
10.1016/S0014-2999(98)00921-2
10.1172/JCI112200
10.1016/S0014-2999(98)00424-5
10.1001/jama.1996.03540140074032
10.1016/S0278-6915(01)00079-5
10.1038/sj.bjp.0705128
10.1172/JCI118074
10.1038/sj.bjp.0704431
10.1073/pnas.88.11.4651
10.1016/0922-4106(90)90031-R
10.1016/j.canlet.2010.01.016
10.1126/science.1235226
10.1038/288373a0
10.1182/blood.V95.3.952.003k27_952_958
10.1038/nrc3004
10.1038/327524a0
10.1016/j.bcp.2003.07.013
10.1021/js990108g
10.1038/nrc2622
10.1093/jnci/83.18.1321
10.1016/S0026-895X(25)10233-2
10.1126/science.1203543
10.1016/S0022-3565(25)10625-3
10.1016/S0022-3565(25)39469-3
10.1016/S0022-3565(25)23490-5
10.1016/S0022-3565(25)23489-9
10.1016/S0022-3565(25)23139-1
10.1208/s12248-013-9559-2
ContentType Journal Article
Copyright The Author(s) 2014
Copyright Nature Publishing Group Mar 2014
Copyright © 2014, Macmillan Publishers Limited. All rights reserved 2014 Macmillan Publishers Limited. All rights reserved
Copyright_xml – notice: The Author(s) 2014
– notice: Copyright Nature Publishing Group Mar 2014
– notice: Copyright © 2014, Macmillan Publishers Limited. All rights reserved 2014 Macmillan Publishers Limited. All rights reserved
DBID C6C
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
88A
88E
88I
8FE
8FH
8FI
8FJ
8FK
ABUWG
AEUYN
AFKRA
AZQEC
BBNVY
BENPR
BHPHI
CCPQU
DWQXO
FYUFA
GHDGH
GNUQQ
HCIFZ
K9.
LK8
M0S
M1P
M2P
M7P
PHGZM
PHGZT
PIMPY
PJZUB
PKEHL
PPXIY
PQEST
PQGLB
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOI 10.1038/srep04344
DatabaseName Springer Nature OA Free Journals
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Biology Database (Alumni Edition)
Medical Database (Alumni Edition)
Science Database (Alumni Edition)
ProQuest SciTech Collection
ProQuest Natural Science Collection
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest One Sustainability
ProQuest Central UK/Ireland
ProQuest Central Essentials
Biological Science Database
ProQuest Central
Natural Science Collection
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Central Student
SciTech Premium Collection
ProQuest Health & Medical Complete (Alumni)
ProQuest Biological Science Collection
Health & Medical Collection (Alumni Edition)
Medical Database
Science Database
Biological Science Database
ProQuest Central Premium
ProQuest One Academic
Publicly Available Content Database
ProQuest Health & Medical Research Collection
ProQuest One Academic Middle East (New)
One Health & Nursing
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Applied & Life Sciences
ProQuest One Academic (retired)
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
SciTech Premium Collection
ProQuest One Community College
ProQuest One Health & Nursing
ProQuest Natural Science Collection
ProQuest Central China
ProQuest Biology Journals (Alumni Edition)
ProQuest Central
ProQuest One Applied & Life Sciences
ProQuest One Sustainability
ProQuest Health & Medical Research Collection
Health Research Premium Collection
Health and Medicine Complete (Alumni Edition)
Natural Science Collection
ProQuest Central Korea
Health & Medical Research Collection
Biological Science Collection
ProQuest Central (New)
ProQuest Medical Library (Alumni)
ProQuest Science Journals (Alumni Edition)
ProQuest Biological Science Collection
ProQuest Central Basic
ProQuest Science Journals
ProQuest One Academic Eastern Edition
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
Biological Science Database
ProQuest SciTech Collection
ProQuest Hospital Collection (Alumni)
ProQuest Health & Medical Complete
ProQuest Medical Library
ProQuest One Academic UKI Edition
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList
MEDLINE - Academic

MEDLINE
Publicly Available Content Database
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: PIMPY
  name: Publicly Available Content Database
  url: http://search.proquest.com/publiccontent
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
EISSN 2045-2322
ExternalDocumentID PMC3949248
24614329
10_1038_srep04344
Genre Research Support, Non-U.S. Gov't
Journal Article
GroupedDBID 0R~
3V.
4.4
53G
5VS
7X7
88A
88E
88I
8FE
8FH
8FI
8FJ
AAFWJ
AAJSJ
AAKDD
ABDBF
ABUWG
ACGFS
ACSMW
ACUHS
ADBBV
ADRAZ
AENEX
AEUYN
AFKRA
AJTQC
ALIPV
ALMA_UNASSIGNED_HOLDINGS
AOIJS
AZQEC
BAWUL
BBNVY
BCNDV
BENPR
BHPHI
BPHCQ
BVXVI
C6C
CCPQU
DIK
DWQXO
EBD
EBS
EJD
ESX
FYUFA
GNUQQ
GROUPED_DOAJ
GX1
HCIFZ
HH5
HMCUK
HYE
KQ8
LK8
M0L
M1P
M2P
M48
M7P
M~E
NAO
OK1
PIMPY
PQQKQ
PROAC
PSQYO
RNT
RNTTT
RPM
SNYQT
UKHRP
AASML
AAYXX
AFFHD
AFPKN
CITATION
EBLON
PHGZM
PHGZT
PJZUB
PPXIY
PQGLB
CGR
CUY
CVF
ECM
EIF
NPM
7XB
8FK
K9.
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
PUEGO
5PM
ID FETCH-LOGICAL-c438t-d989a96eabfbee8e0d95f41a54dbc4d29b80403dc47059b9c601b307de3257bc3
IEDL.DBID M2P
ISICitedReferencesCount 633
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000332534800010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 2045-2322
IngestDate Tue Nov 04 01:46:50 EST 2025
Fri Sep 05 14:36:30 EDT 2025
Tue Oct 07 07:02:50 EDT 2025
Mon Jul 21 05:50:19 EDT 2025
Sat Nov 29 07:58:31 EST 2025
Tue Nov 18 21:08:23 EST 2025
Fri Feb 21 02:38:54 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
License This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c438t-d989a96eabfbee8e0d95f41a54dbc4d29b80403dc47059b9c601b307de3257bc3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
OpenAccessLink https://www.proquest.com/docview/1897802975?pq-origsite=%requestingapplication%
PMID 24614329
PQID 1897802975
PQPubID 2041939
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_3949248
proquest_miscellaneous_1506791834
proquest_journals_1897802975
pubmed_primary_24614329
crossref_citationtrail_10_1038_srep04344
crossref_primary_10_1038_srep04344
springer_journals_10_1038_srep04344
PublicationCentury 2000
PublicationDate 2014-03-11
PublicationDateYYYYMMDD 2014-03-11
PublicationDate_xml – month: 03
  year: 2014
  text: 2014-03-11
  day: 11
PublicationDecade 2010
PublicationPlace London
PublicationPlace_xml – name: London
– name: England
PublicationTitle Scientific reports
PublicationTitleAbbrev Sci Rep
PublicationTitleAlternate Sci Rep
PublicationYear 2014
Publisher Nature Publishing Group UK
Nature Publishing Group
Publisher_xml – name: Nature Publishing Group UK
– name: Nature Publishing Group
References Jia, Stamler (CR18) 1999; 366
Loscalzo, Smick, Andon, Cooke (CR26) 1989; 249
Takada (CR14) 1993; 53
Peichev (CR32) 2000; 95
Jia, Furchgott (CR29) 1993; 267
Plaks, Koopman, Werb (CR3) 2013; 341
Nakae, Takahashi, Kinoshita, Matsumoto, Kinoshita (CR38) 1995; 274
Kubes, Suzuki, Granger (CR21) 1991; 88
Tsao, McEvoy, Drexler, Butcher, Cooke (CR22) 1994; 89
Tsui, Gambino, Wanstall (CR28) 2003; 138
Alby, Auerbach (CR5) 1984; 81
Jia (CR46) 2003; 44
Loscalzo (CR17) 2001; 88
Jaffe, Nachman, Becker, Minick (CR31) 1973; 52
Jia, Pei, Lin, Yang (CR40) 2001; 39
Lauri, Needham, Martin-Padura, Dejana (CR13) 1991; 83
Cooke, Andon, Loscalzo (CR37) 1989; 249
Xu, Liu, Loizidou, Ahmed, Charles (CR24) 2002; 12
CR49
Nakaki, Nakayama, Kato (CR20) 1990; 189
Furchgott (CR30) 1996; 276
Gay, Felding-Habermann (CR45) 2011; 11
Shaffer (CR39) 1991; 256
Lin, Yang, Wang, Jia, Jia (CR27) 1998; 19
Miettinen, Lindenmayer, Chaubal (CR34) 1994; 7
Taichman (CR9) 1991; 2
Chaffer, Weinberg (CR4) 2011; 331
Palmer, Ferrige, Moncada (CR16) 1987; 327
Nguyen, Bos, Massague (CR1) 2009; 9
Jia, Wong (CR19) 2001; 134
Jordan (CR44) 2010; 293
Garthwaite (CR48) 1995; 48
Shao (CR50) 2013; 330
Amano, Takahashi, Kosaka, Kinoshita (CR36) 1994; 24
Zen (CR11) 2008; 3
Jia, Young, Guo (CR47) 1999; 88
Meager (CR8) 1999; 10
Jia, Wu, Guo, Young (CR41) 2000; 391
Honn, Tang (CR12) 1992; 11
Dejana (CR6) 1988; 82
Furchgott, Zawadzki (CR15) 1980; 288
Rice, Bevilacqua (CR7) 1989; 246
Jia (CR23) 2003; 66
De Caterina (CR43) 1995; 96
Ricci-Vitiani (CR33) 2010; 468
Jia, Blantz (CR25) 1998; 354
Tsao, Buitrago, Chan, Cooke (CR42) 1996; 94
Phillips (CR10) 1990; 250
Sethi, Kang (CR2) 2011; 11
Bevilacqua, Pober, Wheeler, Cotran, Gimbrone Jr (CR35) 1985; 76
BFsrep04344_CR49
PS Tsao (BFsrep04344_CR42) 1996; 94
L Jia (BFsrep04344_CR40) 2001; 39
DX Nguyen (BFsrep04344_CR1) 2009; 9
ML Phillips (BFsrep04344_CR10) 1990; 250
RF Furchgott (BFsrep04344_CR30) 1996; 276
L Jia (BFsrep04344_CR23) 2003; 66
L Jia (BFsrep04344_CR29) 1993; 267
CL Chaffer (BFsrep04344_CR4) 2011; 331
JE Shaffer (BFsrep04344_CR39) 1991; 256
L Jia (BFsrep04344_CR25) 1998; 354
A Takada (BFsrep04344_CR14) 1993; 53
L Jia (BFsrep04344_CR41) 2000; 391
J Loscalzo (BFsrep04344_CR17) 2001; 88
L Jia (BFsrep04344_CR19) 2001; 134
I Nakae (BFsrep04344_CR38) 1995; 274
EA Jaffe (BFsrep04344_CR31) 1973; 52
PS Tsao (BFsrep04344_CR22) 1994; 89
MP Bevilacqua (BFsrep04344_CR35) 1985; 76
J Garthwaite (BFsrep04344_CR48) 1995; 48
LJ Gay (BFsrep04344_CR45) 2011; 11
M Lin (BFsrep04344_CR27) 1998; 19
M Amano (BFsrep04344_CR36) 1994; 24
M Miettinen (BFsrep04344_CR34) 1994; 7
A Meager (BFsrep04344_CR8) 1999; 10
P Kubes (BFsrep04344_CR21) 1991; 88
RF Furchgott (BFsrep04344_CR15) 1980; 288
L Alby (BFsrep04344_CR5) 1984; 81
J Loscalzo (BFsrep04344_CR26) 1989; 249
V Plaks (BFsrep04344_CR3) 2013; 341
DY Tsui (BFsrep04344_CR28) 2003; 138
W Xu (BFsrep04344_CR24) 2002; 12
JP Cooke (BFsrep04344_CR37) 1989; 249
GE Rice (BFsrep04344_CR7) 1989; 246
R De Caterina (BFsrep04344_CR43) 1995; 96
KV Honn (BFsrep04344_CR12) 1992; 11
T Nakaki (BFsrep04344_CR20) 1990; 189
RM Palmer (BFsrep04344_CR16) 1987; 327
K Zen (BFsrep04344_CR11) 2008; 3
L Ricci-Vitiani (BFsrep04344_CR33) 2010; 468
L Jia (BFsrep04344_CR46) 2003; 44
N Sethi (BFsrep04344_CR2) 2011; 11
J Shao (BFsrep04344_CR50) 2013; 330
M Peichev (BFsrep04344_CR32) 2000; 95
E Dejana (BFsrep04344_CR6) 1988; 82
D Taichman (BFsrep04344_CR9) 1991; 2
D Lauri (BFsrep04344_CR13) 1991; 83
L Jia (BFsrep04344_CR18) 1999; 366
BF Jordan (BFsrep04344_CR44) 2010; 293
L Jia (BFsrep04344_CR47) 1999; 88
8181143 - Circulation. 1994 May;89(5):2176-82
6592584 - Proc Natl Acad Sci U S A. 1984 Sep;81(18):5739-43
8229764 - J Pharmacol Exp Ther. 1993 Oct;267(1):371-8
21941285 - Nat Rev Cancer. 2011 Oct;11(10):735-48
11696388 - Food Chem Toxicol. 2001 Dec;39(12):1135-43
24031008 - Science. 2013 Sep 13;341(6151):1186-8
10379910 - Cytokine Growth Factor Rev. 1999 Mar;10(1):27-39
12528889 - Cell Res. 2002 Dec;12(5-6):311-20
6253831 - Nature. 1980 Nov 27;288(5789):373-6
21436443 - Science. 2011 Mar 25;331(6024):1559-64
9726628 - Eur J Pharmacol. 1998 Jul 31;354(1):33-41
1963600 - Eur J Pharmacol. 1990 Dec 15;189(6):347-53
1715924 - J Natl Cancer Inst. 1991 Sep 18;83(18):1321-4
2588007 - Science. 1989 Dec 8;246(4935):1303-6
7512718 - Mod Pathol. 1994 Jan;7(1):82-90
19308067 - Nat Rev Cancer. 2009 Apr;9(4):274-84
7898066 - J Cardiovasc Pharmacol. 1994 Dec;24(6):860-6
10375817 - Zhongguo Yao Li Xue Bao. 1998 Sep;19(5):485-8
11739246 - Br J Pharmacol. 2001 Dec;134(8):1697-704
23200672 - Cancer Lett. 2013 Mar 1;330(1):49-56
10720645 - Eur J Pharmacol. 2000 Mar 10;391(1-2):137-44
4355998 - J Clin Invest. 1973 Nov;52(11):2745-56
7678075 - Cancer Res. 1993 Jan 15;53(2):354-61
14609744 - Biochem Pharmacol. 2003 Dec 1;66(11):2193-9
1716464 - Cell Regul. 1991 May;2(5):347-55
10064155 - Eur J Pharmacol. 1999 Jan 29;366(1):79-86
12642387 - Br J Pharmacol. 2003 Mar;138(5):855-64
24442753 - AAPS J. 2014 Mar;16(2):289-98
3495737 - Nature. 1987 Jun 11-17;327(6122):524-6
1675786 - Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4651-5
2659776 - J Pharmacol Exp Ther. 1989 Jun;249(3):726-9
10514343 - J Pharm Sci. 1999 Oct;88(10):981-6
21258396 - Nat Rev Cancer. 2011 Feb;11(2):123-34
21102434 - Nature. 2010 Dec 9;468(7325):824-8
1701274 - Science. 1990 Nov 23;250(4984):1130-2
20144849 - Cancer Lett. 2010 Jul 28;293(2):213-9
11325866 - Circ Res. 2001 Apr 27;88(8):756-62
3877078 - J Clin Invest. 1985 Nov;76(5):2003-11
7544433 - Mol Pharmacol. 1995 Aug;48(2):184-8
8827976 - JAMA. 1996 Oct 9;276(14):1186-8
1423822 - Cancer Metastasis Rev. 1992 Nov;11(3-4):353-75
7616425 - J Pharmacol Exp Ther. 1995 Jul;274(1):40-6
7542286 - J Clin Invest. 1995 Jul;96(1):60-8
18350162 - PLoS One. 2008;3(3):e1826
8840861 - Circulation. 1996 Oct 1;94(7):1682-9
3262629 - J Clin Invest. 1988 Oct;82(4):1466-70
1899703 - J Pharmacol Exp Ther. 1991 Feb;256(2):704-9
10648408 - Blood. 2000 Feb 1;95(3):952-8
2659777 - J Pharmacol Exp Ther. 1989 Jun;249(3):730-4
References_xml – volume: 3
  start-page: e1826
  year: 2008
  ident: CR11
  article-title: CD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migration
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0001826
– volume: 11
  start-page: 353
  year: 1992
  end-page: 375
  ident: CR12
  article-title: Adhesion molecules and tumor cell interaction with endothelium and subendothelial matrix
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/BF01307187
– volume: 88
  start-page: 756
  year: 2001
  end-page: 762
  ident: CR17
  article-title: Nitric oxide insufficiency, platelet activation and arterial thrombosis
  publication-title: Circ Res
  doi: 10.1161/hh0801.089861
– volume: 7
  start-page: 82
  year: 1994
  end-page: 90
  ident: CR34
  article-title: Endothelial cell markers CD31, CD34 and BNH9 antibody to H- and Y-antigens--evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor
  publication-title: Mod Pathol
– ident: CR49
– volume: 2
  start-page: 347
  year: 1991
  ident: CR9
  article-title: Tumor cell surface alpha 4 beta 1 integrin mediates adhesion to vascular endothelium: demonstration of an interaction with the N-terminal domains of INCAM-110/VCAM-1
  publication-title: Cell Regul
  doi: 10.1091/mbc.2.5.347
– volume: 24
  start-page: 860
  year: 1994
  end-page: 866
  ident: CR36
  article-title: Differential inhibition of platelet aggregation and calcium mobilization by nitroglycerin and stabilized nitric oxide
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/00005344-199424060-00002
– volume: 391
  start-page: 137
  year: 2000
  end-page: 144
  ident: CR41
  article-title: Antiangiogenic effects of S-nitrosocaptopril crystals as a nitric oxide donor
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(99)00794-3
– volume: 468
  start-page: 824
  year: 2010
  end-page: 828
  ident: CR33
  article-title: Tumour vascularization via endothelial differentiation of glioblastoma stem-like cells
  publication-title: Nature
  doi: 10.1038/nature09557
– volume: 12
  start-page: 311
  year: 2002
  end-page: 320
  ident: CR24
  article-title: The role of nitric oxide in cancer
  publication-title: Cell Res
  doi: 10.1038/sj.cr.7290133
– volume: 94
  start-page: 1682
  year: 1996
  end-page: 1689
  ident: CR42
  article-title: Fluid flow inhibits endothelial adhesiveness nitric oxide and transcriptional regulation of VCAM-1
  publication-title: Circulation
  doi: 10.1161/01.CIR.94.7.1682
– volume: 81
  start-page: 5739
  year: 1984
  end-page: 5743
  ident: CR5
  article-title: Differential adhesion of tumor cells to capillary endothelial cells in vitro
  publication-title: Proc Natl Acad of Sci USA
  doi: 10.1073/pnas.81.18.5739
– volume: 10
  start-page: 27
  year: 1999
  end-page: 39
  ident: CR8
  article-title: Cytokine regulation of cellular adhesion molecule expression in inflammation
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/S1359-6101(98)00024-0
– volume: 44
  start-page: 1059
  year: 2003
  ident: CR46
  article-title: EDRF-like activity and anticancer spectrum of JS-K, a novel diazeniumdiolate nitric oxide donor
  publication-title: Proc. Am. Assoc. Cancer Res
– volume: 11
  start-page: 735
  year: 2011
  end-page: 748
  ident: CR2
  article-title: Unravelling the complexity of metastasis - molecular understanding and targeted therapies
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3125
– volume: 52
  start-page: 2745
  year: 1973
  end-page: 2756
  ident: CR31
  article-title: Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria
  publication-title: J Clin Invest
  doi: 10.1172/JCI107470
– volume: 249
  start-page: 730
  year: 1989
  end-page: 734
  ident: CR37
  article-title: Effects on vascular reactivity
  publication-title: J Pharmacol Exp Ther
– volume: 330
  start-page: 49
  year: 2013
  end-page: 56
  ident: CR50
  article-title: Intracellular distribution and mechanisms of actions of photosensitizer Zinc(II)-phthalocyanine solubilized in Cremophor EL against human hepatocellular carcinoma HepG2 cells
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2012.11.017
– volume: 89
  start-page: 2176
  year: 1994
  end-page: 2182
  ident: CR22
  article-title: Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine
  publication-title: Circulation
  doi: 10.1161/01.CIR.89.5.2176
– volume: 82
  start-page: 1466
  year: 1988
  ident: CR6
  article-title: Interleukin 1 promotes tumor cell adhesion to cultured human endothelial cells
  publication-title: J Clin Invest
  doi: 10.1172/JCI113753
– volume: 246
  start-page: 1303
  year: 1989
  end-page: 1306
  ident: CR7
  article-title: An inducible endothelial cell surface glycoprotein mediates melanoma adhesion
  publication-title: Science
  doi: 10.1126/science.2588007
– volume: 250
  start-page: 1130
  year: 1990
  end-page: 1132
  ident: CR10
  article-title: ELAM-1 mediates cell adhesion by recognition of a carbohydrate ligand, sialyl-Lex
  publication-title: Science
  doi: 10.1126/science.1701274
– volume: 256
  start-page: 704
  year: 1991
  end-page: 709
  ident: CR39
  article-title: The hemodynamic effects of S-nitrosocaptopril in anesthetized dogs
  publication-title: J Pharmacol Exp Ther
– volume: 366
  start-page: 79
  year: 1999
  end-page: 86
  ident: CR18
  article-title: Dual actions of S-nitrosylated derivative of vasoactive intestinal peptide as a vasoactive intestinal peptide-like mediator and a nitric oxide carrier
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(98)00921-2
– volume: 76
  start-page: 2003
  year: 1985
  end-page: 2011
  ident: CR35
  article-title: Interleukin 1 acts on cultured human vascular endothelium to increase the adhesion of polymorphonuclear leukocytes, monocytes and related leukocyte cell lines
  publication-title: J Clin Invest
  doi: 10.1172/JCI112200
– volume: 354
  start-page: 33
  year: 1998
  end-page: 41
  ident: CR25
  article-title: The effects of S-nitrosocaptopril on renal filtration and blood pressure in rats
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(98)00424-5
– volume: 48
  start-page: 184
  year: 1995
  end-page: 188
  ident: CR48
  article-title: Potent and selective inhibition of nitric oxide-sensitive guanylyl cyclase by 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one
  publication-title: Mol Pharmacol
– volume: 276
  start-page: 1186
  year: 1996
  end-page: 1188
  ident: CR30
  article-title: The 1996 Albert Lasker Medical Research Awards. The discovery of endothelium-derived relaxing factor and its importance in the identification of nitric oxide
  publication-title: JAMA
  doi: 10.1001/jama.1996.03540140074032
– volume: 53
  start-page: 354
  year: 1993
  end-page: 361
  ident: CR14
  article-title: Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium
  publication-title: Cancer Res
– volume: 39
  start-page: 1135
  year: 2001
  end-page: 1143
  ident: CR40
  article-title: Acute and subacute toxicity and efficacy of S-nitrosylated captopril, an ACE inhibitor possessing nitric oxide activities
  publication-title: Food Chem Toxicol
  doi: 10.1016/S0278-6915(01)00079-5
– volume: 138
  start-page: 855
  year: 2003
  end-page: 864
  ident: CR28
  article-title: S-nitrosocaptopril: in vitro characterization of pulmonary vascular effects in rats
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0705128
– volume: 96
  start-page: 60
  year: 1995
  ident: CR43
  article-title: Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines
  publication-title: J Clin Invest
  doi: 10.1172/JCI118074
– volume: 134
  start-page: 1697
  year: 2001
  end-page: 1704
  ident: CR19
  article-title: In vitro and in vivo assessment of cellular permeability and pharmacodynamics of S-nitrosylated captopril, a nitric oxide donor
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0704431
– volume: 274
  start-page: 40
  year: 1995
  end-page: 46
  ident: CR38
  article-title: The effects of S-nitrosocaptopril on canine coronary circulation
  publication-title: J Pharmacol Exp Ther
– volume: 88
  start-page: 4651
  year: 1991
  end-page: 4655
  ident: CR21
  article-title: Nitric oxide: an endogenous modulator of leukocyte adhesion
  publication-title: Proc Natl Acad of Sci USA
  doi: 10.1073/pnas.88.11.4651
– volume: 189
  start-page: 347
  year: 1990
  end-page: 353
  ident: CR20
  article-title: Inhibition by nitric oxide and nitric oxide-producing vasodilators of DNA synthesis in vascular smooth muscle cells
  publication-title: Eur J Pharmacol
  doi: 10.1016/0922-4106(90)90031-R
– volume: 293
  start-page: 213
  year: 2010
  end-page: 219
  ident: CR44
  article-title: Captopril and S-nitrosocaptopril as potent radiosensitizers: Comparative study and underlying mechanisms
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2010.01.016
– volume: 341
  start-page: 1186
  year: 2013
  end-page: 1188
  ident: CR3
  article-title: Cancer. Circulating tumor cells
  publication-title: Science
  doi: 10.1126/science.1235226
– volume: 19
  start-page: 485
  year: 1998
  ident: CR27
  article-title: Inhibitory effects of S-nitrosocaptopril on vasomotor tone
  publication-title: Acta Pharmacol Sin
– volume: 288
  start-page: 373
  year: 1980
  end-page: 376
  ident: CR15
  article-title: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine
  publication-title: Nature
  doi: 10.1038/288373a0
– volume: 249
  start-page: 726
  year: 1989
  end-page: 729
  ident: CR26
  article-title: S-nitrosocaptopril. I. Molecular characterization and effects on the vasculature and on platelets
  publication-title: J Pharmacol Exp Ther
– volume: 267
  start-page: 371
  year: 1993
  end-page: 378
  ident: CR29
  article-title: Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor
  publication-title: J Pharmacol Exp Ther
– volume: 95
  start-page: 952
  year: 2000
  end-page: 958
  ident: CR32
  article-title: Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors
  publication-title: Blood
  doi: 10.1182/blood.V95.3.952.003k27_952_958
– volume: 11
  start-page: 123
  year: 2011
  end-page: 134
  ident: CR45
  article-title: Contribution of platelets to tumour metastasis
  publication-title: Na Rev Cancer
  doi: 10.1038/nrc3004
– volume: 327
  start-page: 524
  year: 1987
  end-page: 526
  ident: CR16
  article-title: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
  publication-title: Nature
  doi: 10.1038/327524a0
– volume: 66
  start-page: 2193
  year: 2003
  end-page: 2199
  ident: CR23
  article-title: Effect of nitric oxide on cytotoxicity of Taxol: enhanced Taxol transcellular permeability
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2003.07.013
– volume: 88
  start-page: 981
  year: 1999
  end-page: 986
  ident: CR47
  article-title: Physicochemistry, pharmacokinetics and pharmacodynamics of S-nitrosocaptopril crystals, a new nitric oxide donor
  publication-title: J Pharm Sci
  doi: 10.1021/js990108g
– volume: 9
  start-page: 274
  year: 2009
  end-page: 284
  ident: CR1
  article-title: Metastasis: from dissemination to organ-specific colonization
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2622
– volume: 331
  start-page: 1559
  year: 2011
  end-page: 1564
  ident: CR4
  article-title: A perspective on cancer cell metastasis
  publication-title: Science
– volume: 83
  start-page: 1321
  year: 1991
  end-page: 1324
  ident: CR13
  article-title: Tumor cell adhesion to endothelial cells: endothelial leukocyte adhesion molecule-1 as an inducible adhesive receptor specific for colon carcinoma cells
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/83.18.1321
– volume: 53
  start-page: 354
  year: 1993
  ident: BFsrep04344_CR14
  publication-title: Cancer Res
– volume: 138
  start-page: 855
  year: 2003
  ident: BFsrep04344_CR28
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0705128
– volume: 88
  start-page: 756
  year: 2001
  ident: BFsrep04344_CR17
  publication-title: Circ Res
  doi: 10.1161/hh0801.089861
– volume: 94
  start-page: 1682
  year: 1996
  ident: BFsrep04344_CR42
  publication-title: Circulation
  doi: 10.1161/01.CIR.94.7.1682
– volume: 2
  start-page: 347
  year: 1991
  ident: BFsrep04344_CR9
  publication-title: Cell Regul
  doi: 10.1091/mbc.2.5.347
– volume: 44
  start-page: 1059
  year: 2003
  ident: BFsrep04344_CR46
  publication-title: Proc. Am. Assoc. Cancer Res
– volume: 48
  start-page: 184
  year: 1995
  ident: BFsrep04344_CR48
  publication-title: Mol Pharmacol
  doi: 10.1016/S0026-895X(25)10233-2
– volume: 331
  start-page: 1559
  year: 2011
  ident: BFsrep04344_CR4
  publication-title: Science
  doi: 10.1126/science.1203543
– volume: 288
  start-page: 373
  year: 1980
  ident: BFsrep04344_CR15
  publication-title: Nature
  doi: 10.1038/288373a0
– volume: 88
  start-page: 981
  year: 1999
  ident: BFsrep04344_CR47
  publication-title: J Pharm Sci
  doi: 10.1021/js990108g
– volume: 76
  start-page: 2003
  year: 1985
  ident: BFsrep04344_CR35
  publication-title: J Clin Invest
  doi: 10.1172/JCI112200
– volume: 189
  start-page: 347
  year: 1990
  ident: BFsrep04344_CR20
  publication-title: Eur J Pharmacol
  doi: 10.1016/0922-4106(90)90031-R
– volume: 293
  start-page: 213
  year: 2010
  ident: BFsrep04344_CR44
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2010.01.016
– volume: 19
  start-page: 485
  year: 1998
  ident: BFsrep04344_CR27
  publication-title: Acta Pharmacol Sin
– volume: 276
  start-page: 1186
  year: 1996
  ident: BFsrep04344_CR30
  publication-title: JAMA
  doi: 10.1001/jama.1996.03540140074032
– volume: 274
  start-page: 40
  year: 1995
  ident: BFsrep04344_CR38
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)10625-3
– volume: 39
  start-page: 1135
  year: 2001
  ident: BFsrep04344_CR40
  publication-title: Food Chem Toxicol
  doi: 10.1016/S0278-6915(01)00079-5
– volume: 95
  start-page: 952
  year: 2000
  ident: BFsrep04344_CR32
  publication-title: Blood
  doi: 10.1182/blood.V95.3.952.003k27_952_958
– volume: 267
  start-page: 371
  year: 1993
  ident: BFsrep04344_CR29
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)39469-3
– volume: 7
  start-page: 82
  year: 1994
  ident: BFsrep04344_CR34
  publication-title: Mod Pathol
– volume: 366
  start-page: 79
  year: 1999
  ident: BFsrep04344_CR18
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(98)00921-2
– volume: 249
  start-page: 730
  year: 1989
  ident: BFsrep04344_CR37
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)23490-5
– volume: 134
  start-page: 1697
  year: 2001
  ident: BFsrep04344_CR19
  publication-title: Br J Pharmacol
  doi: 10.1038/sj.bjp.0704431
– volume: 330
  start-page: 49
  year: 2013
  ident: BFsrep04344_CR50
  publication-title: Cancer Lett
  doi: 10.1016/j.canlet.2012.11.017
– volume: 341
  start-page: 1186
  year: 2013
  ident: BFsrep04344_CR3
  publication-title: Science
  doi: 10.1126/science.1235226
– volume: 468
  start-page: 824
  year: 2010
  ident: BFsrep04344_CR33
  publication-title: Nature
  doi: 10.1038/nature09557
– volume: 354
  start-page: 33
  year: 1998
  ident: BFsrep04344_CR25
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(98)00424-5
– volume: 249
  start-page: 726
  year: 1989
  ident: BFsrep04344_CR26
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)23489-9
– volume: 11
  start-page: 123
  year: 2011
  ident: BFsrep04344_CR45
  publication-title: Na Rev Cancer
  doi: 10.1038/nrc3004
– volume: 83
  start-page: 1321
  year: 1991
  ident: BFsrep04344_CR13
  publication-title: J Natl Cancer Inst
  doi: 10.1093/jnci/83.18.1321
– volume: 327
  start-page: 524
  year: 1987
  ident: BFsrep04344_CR16
  publication-title: Nature
  doi: 10.1038/327524a0
– volume: 256
  start-page: 704
  year: 1991
  ident: BFsrep04344_CR39
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(25)23139-1
– volume: 88
  start-page: 4651
  year: 1991
  ident: BFsrep04344_CR21
  publication-title: Proc Natl Acad of Sci USA
  doi: 10.1073/pnas.88.11.4651
– volume: 250
  start-page: 1130
  year: 1990
  ident: BFsrep04344_CR10
  publication-title: Science
  doi: 10.1126/science.1701274
– volume: 81
  start-page: 5739
  year: 1984
  ident: BFsrep04344_CR5
  publication-title: Proc Natl Acad of Sci USA
  doi: 10.1073/pnas.81.18.5739
– volume: 246
  start-page: 1303
  year: 1989
  ident: BFsrep04344_CR7
  publication-title: Science
  doi: 10.1126/science.2588007
– volume: 3
  start-page: e1826
  year: 2008
  ident: BFsrep04344_CR11
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0001826
– volume: 96
  start-page: 60
  year: 1995
  ident: BFsrep04344_CR43
  publication-title: J Clin Invest
  doi: 10.1172/JCI118074
– volume: 82
  start-page: 1466
  year: 1988
  ident: BFsrep04344_CR6
  publication-title: J Clin Invest
  doi: 10.1172/JCI113753
– volume: 11
  start-page: 353
  year: 1992
  ident: BFsrep04344_CR12
  publication-title: Cancer Metastasis Rev
  doi: 10.1007/BF01307187
– volume: 391
  start-page: 137
  year: 2000
  ident: BFsrep04344_CR41
  publication-title: Eur J Pharmacol
  doi: 10.1016/S0014-2999(99)00794-3
– ident: BFsrep04344_CR49
  doi: 10.1208/s12248-013-9559-2
– volume: 89
  start-page: 2176
  year: 1994
  ident: BFsrep04344_CR22
  publication-title: Circulation
  doi: 10.1161/01.CIR.89.5.2176
– volume: 11
  start-page: 735
  year: 2011
  ident: BFsrep04344_CR2
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc3125
– volume: 9
  start-page: 274
  year: 2009
  ident: BFsrep04344_CR1
  publication-title: Nat Rev Cancer
  doi: 10.1038/nrc2622
– volume: 12
  start-page: 311
  year: 2002
  ident: BFsrep04344_CR24
  publication-title: Cell Res
  doi: 10.1038/sj.cr.7290133
– volume: 10
  start-page: 27
  year: 1999
  ident: BFsrep04344_CR8
  publication-title: Cytokine Growth Factor Rev
  doi: 10.1016/S1359-6101(98)00024-0
– volume: 24
  start-page: 860
  year: 1994
  ident: BFsrep04344_CR36
  publication-title: J Cardiovasc Pharmacol
  doi: 10.1097/00005344-199424060-00002
– volume: 52
  start-page: 2745
  year: 1973
  ident: BFsrep04344_CR31
  publication-title: J Clin Invest
  doi: 10.1172/JCI107470
– volume: 66
  start-page: 2193
  year: 2003
  ident: BFsrep04344_CR23
  publication-title: Biochem Pharmacol
  doi: 10.1016/j.bcp.2003.07.013
– reference: 3495737 - Nature. 1987 Jun 11-17;327(6122):524-6
– reference: 24031008 - Science. 2013 Sep 13;341(6151):1186-8
– reference: 12642387 - Br J Pharmacol. 2003 Mar;138(5):855-64
– reference: 4355998 - J Clin Invest. 1973 Nov;52(11):2745-56
– reference: 10514343 - J Pharm Sci. 1999 Oct;88(10):981-6
– reference: 21436443 - Science. 2011 Mar 25;331(6024):1559-64
– reference: 6592584 - Proc Natl Acad Sci U S A. 1984 Sep;81(18):5739-43
– reference: 1701274 - Science. 1990 Nov 23;250(4984):1130-2
– reference: 21258396 - Nat Rev Cancer. 2011 Feb;11(2):123-34
– reference: 10375817 - Zhongguo Yao Li Xue Bao. 1998 Sep;19(5):485-8
– reference: 7544433 - Mol Pharmacol. 1995 Aug;48(2):184-8
– reference: 10720645 - Eur J Pharmacol. 2000 Mar 10;391(1-2):137-44
– reference: 1963600 - Eur J Pharmacol. 1990 Dec 15;189(6):347-53
– reference: 14609744 - Biochem Pharmacol. 2003 Dec 1;66(11):2193-9
– reference: 10379910 - Cytokine Growth Factor Rev. 1999 Mar;10(1):27-39
– reference: 18350162 - PLoS One. 2008;3(3):e1826
– reference: 1899703 - J Pharmacol Exp Ther. 1991 Feb;256(2):704-9
– reference: 9726628 - Eur J Pharmacol. 1998 Jul 31;354(1):33-41
– reference: 7616425 - J Pharmacol Exp Ther. 1995 Jul;274(1):40-6
– reference: 10648408 - Blood. 2000 Feb 1;95(3):952-8
– reference: 1423822 - Cancer Metastasis Rev. 1992 Nov;11(3-4):353-75
– reference: 8840861 - Circulation. 1996 Oct 1;94(7):1682-9
– reference: 7542286 - J Clin Invest. 1995 Jul;96(1):60-8
– reference: 24442753 - AAPS J. 2014 Mar;16(2):289-98
– reference: 19308067 - Nat Rev Cancer. 2009 Apr;9(4):274-84
– reference: 2659777 - J Pharmacol Exp Ther. 1989 Jun;249(3):730-4
– reference: 2659776 - J Pharmacol Exp Ther. 1989 Jun;249(3):726-9
– reference: 1675786 - Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):4651-5
– reference: 8827976 - JAMA. 1996 Oct 9;276(14):1186-8
– reference: 10064155 - Eur J Pharmacol. 1999 Jan 29;366(1):79-86
– reference: 6253831 - Nature. 1980 Nov 27;288(5789):373-6
– reference: 7898066 - J Cardiovasc Pharmacol. 1994 Dec;24(6):860-6
– reference: 21102434 - Nature. 2010 Dec 9;468(7325):824-8
– reference: 2588007 - Science. 1989 Dec 8;246(4935):1303-6
– reference: 11739246 - Br J Pharmacol. 2001 Dec;134(8):1697-704
– reference: 12528889 - Cell Res. 2002 Dec;12(5-6):311-20
– reference: 21941285 - Nat Rev Cancer. 2011 Oct;11(10):735-48
– reference: 7678075 - Cancer Res. 1993 Jan 15;53(2):354-61
– reference: 7512718 - Mod Pathol. 1994 Jan;7(1):82-90
– reference: 3877078 - J Clin Invest. 1985 Nov;76(5):2003-11
– reference: 1716464 - Cell Regul. 1991 May;2(5):347-55
– reference: 23200672 - Cancer Lett. 2013 Mar 1;330(1):49-56
– reference: 8229764 - J Pharmacol Exp Ther. 1993 Oct;267(1):371-8
– reference: 8181143 - Circulation. 1994 May;89(5):2176-82
– reference: 11696388 - Food Chem Toxicol. 2001 Dec;39(12):1135-43
– reference: 1715924 - J Natl Cancer Inst. 1991 Sep 18;83(18):1321-4
– reference: 11325866 - Circ Res. 2001 Apr 27;88(8):756-62
– reference: 20144849 - Cancer Lett. 2010 Jul 28;293(2):213-9
– reference: 3262629 - J Clin Invest. 1988 Oct;82(4):1466-70
SSID ssj0000529419
Score 2.6025681
Snippet Adhesion of circulating tumor cells (CTCs) to vascular endothelial bed becomes a crucial starting point in metastatic cascade. We hypothesized that nitric...
SourceID pubmedcentral
proquest
pubmed
crossref
springer
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 4344
SubjectTerms 13/106
13/21
13/31
13/95
14/1
14/34
14/63
631/154/436
631/337
631/67/2195
631/80/79
82/29
82/80
Adhesion
Cancer
Captopril - analogs & derivatives
Captopril - chemistry
Captopril - pharmacology
Cell adhesion & migration
Cell Adhesion - drug effects
Cell adhesion molecules
Cell cycle
Cell Cycle - drug effects
Cell Line, Tumor
Cell Survival - drug effects
Colorectal carcinoma
Cytokines
Cytokines - pharmacology
Cytotoxicity
Endothelial cells
Endothelium
Endothelium, Vascular - cytology
Endothelium, Vascular - drug effects
Enzyme Inhibitors - pharmacology
Gene Expression - drug effects
Guanylate cyclase
Guanylate Cyclase - antagonists & inhibitors
Guanylate Cyclase - metabolism
Hemoglobin
Hemoglobins - pharmacology
Human Umbilical Vein Endothelial Cells - cytology
Human Umbilical Vein Endothelial Cells - drug effects
Humanities and Social Sciences
Humans
Membrane potential
Metastases
Metastasis
Mitochondria
multidisciplinary
Neoplasm Metastasis - prevention & control
Neoplastic Cells, Circulating - drug effects
Neoplastic Cells, Circulating - pathology
Nitric oxide
Nitric Oxide - antagonists & inhibitors
Nitric Oxide - chemistry
Nitric Oxide - pharmacology
Nitric Oxide Donors - chemistry
Nitric Oxide Donors - pharmacology
Science
Tumor cells
Umbilical vein
Vascular cell adhesion molecule 1
Vascular Cell Adhesion Molecule-1 - genetics
Vascular Cell Adhesion Molecule-1 - metabolism
Vasodilation
Vasodilation - drug effects
Title Nitric Oxide Inhibits Hetero-adhesion of Cancer Cells to Endothelial Cells: Restraining Circulating Tumor Cells from Initiating Metastatic Cascade
URI https://link.springer.com/article/10.1038/srep04344
https://www.ncbi.nlm.nih.gov/pubmed/24614329
https://www.proquest.com/docview/1897802975
https://www.proquest.com/docview/1506791834
https://pubmed.ncbi.nlm.nih.gov/PMC3949248
Volume 4
WOSCitedRecordID wos000332534800010&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAON
  databaseName: DOAJ Directory of Open Access Journals
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: DOA
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.doaj.org/
  providerName: Directory of Open Access Journals
– providerCode: PRVHPJ
  databaseName: ROAD: Directory of Open Access Scholarly Resources
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M~E
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://road.issn.org
  providerName: ISSN International Centre
– providerCode: PRVPQU
  databaseName: Biological Science Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M7P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/biologicalscijournals
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Health & Medical Collection
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: 7X7
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/healthcomplete
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: ProQuest Central
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: BENPR
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://www.proquest.com/central
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Publicly Available Content Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: PIMPY
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: http://search.proquest.com/publiccontent
  providerName: ProQuest
– providerCode: PRVPQU
  databaseName: Science Database
  customDbUrl:
  eissn: 2045-2322
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0000529419
  issn: 2045-2322
  databaseCode: M2P
  dateStart: 20110101
  isFulltext: true
  titleUrlDefault: https://search.proquest.com/sciencejournals
  providerName: ProQuest
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpR1db9Mw0GIrSLzwPRYYlfl44CVak7jE5gVB1GmTaImmIZWnyo4vaqQuKU2K4G_wi7nLF3RDvPBiRbEdX3Tn8_k-GXslpdDGCz0XjFYucj_rapWCKzwdKt8Hz0IdKPwxnM3kfK7iVuFWtm6VHU-sGbUtEtKRH3uScuVQHOi79VeXqkaRdbUtobHHBijZeOTSNfXjXsdCVizhqS6hUCCP8dhZj0QgxO4xdE22vO4iecVOWh8_J3f_F_B77E4rePL3DaXcZzcgf8BuNaUofzxkP2cZ5ernn75nFvhZvsxMVpX8lLxlClfbJZBajRcpj4hONjyC1arkVcEnuaUorhUScvPyLT-Hsis9waNsk9QlwvD5YntZdDMprgXXyaqs6ZtCpSm6CWGIdEle-4_Y55PJRXTqtvUa3EQEsnKtkkqrN6BNagAkjKwap4j0sbAmEdZXRiLLCGwiQhTqjErwMmiQx1gIkHGYJDhg-3mRwyHjqRJg0hFOHWkUcRTxbA-vRiDHoIwBh73u0LdI2mTm9GOrRW1UD-Six7TDXvRD100Gj78NOuqQt2g3cbn4jTmHPe-7cfuRTUXnUGxxzJg0ccgX8ROPG5LpV6FUfSLwlcPCHWLqB1Bq792ePFvWKb4DJfBiLB32siO7P8C6CvyTfwP_lN1GKU-Q45znHbH9arOFZ-xm8q3Kys2Q7YXzsG7lkA0-TGbx-bBWTAzrvURtiO0gPpvGX34BF_UtBQ
linkProvider ProQuest
linkToHtml http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEB6VAoIL70egwPKSuFiN7Q3ZRUIIhVaJmoYKFak3s-sdK5aCHWIH6N_gh_AbmbFjQ1rErQdulvc1Xn8zO7s7D4BnSklj_b7voTXaI-nnPKMT9KRv-joI0HdYOQqP-5OJOjrSBxvws_GFYbPKRiZWgtrlMZ-Rb_uKY-WwH-ib-RePs0bx7WqTQqOGxR4ef6MtW_F69I7-7_Mg2N05HAy9VVYBL5ahKj2nlTb6JRqbWESFXad7CZHWk87G0gXaKgJ26GLZJ9XD6pi2LJY4wWFI8LZxSP2eg_OSI4uxqWBw0J7p8K2Z9HUTwChU27TMzbsylHJ92Tuly542yTxxL1std7tX_7eJugZXVoq1eFtzwnXYwOwGXKxTbR7fhB-TlHMRiPffU4dilE1Tm5aFGLI1UO4ZN0U-NhR5IgbMBwsxwNmsEGUudjLHXmozYtT65SvxAYsmtYYYpIu4SoFGz4fLz3nTkv12aJy0TOuyfSwNe28RDQNTsFfCLfh4JhNyGzazPMO7IBIt0SZdato1pMJpXpN82vqh6qG2FjvwooFLFK-CtfOHzaLKaCBUUYusDjxpq87rCCV_q7TVgCVaCaki-o2UDjxui0m88J2RyTBfUp0enzSS3Kcu7tQQbUfhUIQyDHQH-mvgbStw6PL1kiydViHMQy1p46868LSB-R9knST-3r-JfwSXhof742g8muzdh8uk0Uo2EvT9LdgsF0t8ABfir2VaLB5W3Crg01mj_hcCSYRf
linkToPdf http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1bb9MwFLZGB4gX7pfCAHOTeInaJC6xkRBC3apV20qFNmk8BTs-USOVpDQpsL_Bz-HXcU5u0A3xtgfeotixT5LvXGyfC2PPpRTauIHrgNHKQelnHa1icISrA-V54FooA4X3g8lEHh-r6Qb72cTCkFtlIxNLQW2ziPbIe66kXDkUB9qLa7eI6fbo7eKLQxWk6KS1KadRQWQPTr7h8i1_M97Gf_3C80Y7h8Ndp64w4ETCl4VjlVRavQJtYgMgoW_VIEYyB8KaSFhPGYkg920kAjRDjIpw-WKQKyz4CHUT-TjuBbaJJrnwOmxzOj6Yfmx3eOgMTbiqSWfkyx4qvUVf-EKsK8Ezlu1ZB81Tp7Sl8htd-58_23V2tTa5-buKR26wDUhvsktVEc6TW-zHJKEqBfz998QCH6ezxCRFznfJTyhztJ0BbSjyLOZD4pAlH8J8nvMi4zuppfi1ObJwdfM1_wB5U3SDD5NlVBZHw-vD1eeseZIienCepEiqtgMoNMV1IQ1DnVO8wm12dC4f5A7rpFkK9xiPlQAT9_HRvkbjTpG2cnFRCHIAyhjospcNdMKoTuNOLzYPS3cCX4Ytyrrsadt1UeUu-VunrQY4YS2-8vA3arrsSduMgodOk3QK2Qr7DGgPEjUCDnG3gms7CyUpFL6nuixYA3LbgZKar7ekyaxMbu4roTwhu-xZA_k_yDpN_P1_E_-YXUawh_vjyd4DdgVNXUHeg667xTrFcgUP2cXoa5Hky0c163L26bxh_wtgoI6o
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Nitric+Oxide+Inhibits+Hetero-adhesion+of+Cancer+Cells+to+Endothelial+Cells%3A+Restraining+Circulating+Tumor+Cells+from+Initiating+Metastatic+Cascade&rft.jtitle=Scientific+reports&rft.au=Lu%2C+Yusheng&rft.au=Yu%2C+Ting&rft.au=Liang%2C+Haiyan&rft.au=Wang%2C+Jichuang&rft.date=2014-03-11&rft.issn=2045-2322&rft.eissn=2045-2322&rft.volume=4&rft.issue=1&rft_id=info:doi/10.1038%2Fsrep04344&rft.externalDBID=n%2Fa&rft.externalDocID=10_1038_srep04344
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2045-2322&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2045-2322&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2045-2322&client=summon